utah

Halia Therapeutics Completes Enrollment in Phase 2a Clinical Trial of HT-6184 for Myelodysplastic Syndrome (MDS)

LEHI, Utah, June 4, 2025 /PRNewswire/ -- Halia Therapeutics, a clinical-stage biopharmaceutical company pioneering therapies inspired by genetic resilience, today…

4 weeks ago

TruGolf to Paricipate in the 2025 Virtual Tech Conference: Discover the Innovations Reshaping Tomorrow Conference Presented by Maxim Group LLC on Wednesday, June 4th at 3:00 PM EDT

Salt Lake City, Utah, June 03, 2025 (GLOBE NEWSWIRE) -- TruGolf Holdings, Inc. (NASDAQ: TRUG), a leading golf technology company,…

4 weeks ago